Josh Wolfe insider trades: Eikon Therapeutics (EIKN) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Josh reports to the SEC
and 2 more companies
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | EIKN | ↑ Buy | 138,888 | $18.00 | $2.5M | Indirect | Feb 6, 2026 (2d) |
| Feb 4, 2026 | EIKN | ↑ Buy | 138,888 | $18.00 | $2.5M | Indirect | Feb 6, 2026 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EIKN insiders
Open-market trades in the last 12 months
About Josh Wolfe's insider trades
Josh Wolfe is an insider at Eikon Therapeutics (EIKN). Since Feb 4, 2026, Josh has reported 2 open-market purchases worth $5.0M and no sales on SEC Form 4. In the last 12 months: 2 buys ($5.0M).
Their filings also include other transactions (7 filings), grants and awards (3 filings), conversions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EIKN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.